#1 in Research Worldwide
U.S. News & World Report ranks UC San Diego #1 in the world for gastroenterology and hepatology (liver) research, based on our physicians' research reputation and publications.
Learn more about this ranking.
Clinical trials of innovative therapies designed to halt the progression of and reverse liver injury are currently underway at UC San Diego Health.
Through research, important advances in the treatment of liver disease continues to emerge.
Currently we have several drug trials and observational studies mainly related to Nonalcoholic Fatty Liver Disease (NAFLD) and pharmaceutical trials for patients with NAFLD, nonalcoholic steatohepatitis (NASH), and NASH cirrhosis. For information, call 858-246-2179.